Skip to content
Annika Bansal – Lifestyle
Author:
AGC Biologics, Inc.
Global Pharmaceutical Company Commits to a Dual-Site Deal with AGC Biologics Exceeding €0.5 Billion
November 3, 2026
Flen Health Chooses AGC Biologics to Manufacture Recombinant Enzymes for Next-Generation Wound Treatment
September 24, 2026
AGC Biologics Lands Commercial Manufacturing Agreement for Yokohama Site Worth Hundreds of Millions of Dollars
July 28, 2026
AGC Biologics Expands to Fill-Finish in U.S. Through Strategic Partnership with Pyramid Pharma Services
June 30, 2026
AGC Biologics to Manufacture Teikoku Seiyaku’s rhMMP-7 Drug Substance
May 25, 2026
AGC Biologics Joins Orphan Therapeutics Accelerator’s Clinical Development Network as a Manufacturing Partner to Advance Cell and Gene Therapies for Ultra-Rare Diseases
May 11, 2026